Overview

Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed Conditions

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Montelukast Chewable Tablet under fed conditions
Phase:
Early Phase 1
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Montelukast